Here, we present our method, TamGen, which not only achieved state-of-the-art performance in benchmark testing but also discovered several compounds with high inhibitory activities against the ClpP protease of Mycobacterium tuberculosis, the causative pathogen of tuberculosis. This evidence concerns the gene CLPP and tuberculosis.